Definium Therapeutics
The Senior Director, Trade & Distribution at Definium Therapeutics designs, builds, and manages the commercial distribution and channel strategy for DT-120 ODT, ensuring patient and provider access through partnerships with key trade partners.
Headquarters
New York, New York, United States
Company Size
1-10 employees
Founded
2019
Definium Therapeutics (formerly MindMed) is a clinical-stage biopharmaceutical company harnessing the therapeutic potential of psychedelic medicine to develop treatments for psychiatric conditions including generalized anxiety disorder, major depressive disorder, and autism spectrum disorder. Its lead programs include DT120 ODT, a proprietary formulation of lysergide (LSD) D-tartrate, and DT402, the R-enantiomer of MDMA targeting core symptoms of autism spectrum disorder. The company is guided by precision science and evidence-based development to redefine mental healthcare.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Definium Therapeutics.
62% above the average for this role
Sr. Director of Trade and Distribution
Praxis Precision Medicines, Inc.
Associate Director, Trade Contracting Analytics
1080030P
Director, Trade Relations
Dyne Therapeutics
Director, Trade and Distribution
Deciphera Pharmaceuticals
Director, Trade and Distribution
Deciphera Pharmaceuticals
VP, PBM Trade Relations
Navitus Health Solutions, LLC